Back

Androgen Receptor Gene Expression in Prostate Cancer is Directly Suppressed by the Androgen Receptor Through Recruitment of Lysine-Specific Demethylase 1

Back

Inhibition of LSD1 disrupts global EWS/ETS transcriptional function in Ewing sarcoma

Back

High-throughput virtual screening identifies novel N’-(1-phenylethylidene)-benzohydrazides as potent, specific, and reversible LSD1 inhibitors

Back

LSD1 activates a lethal prostate cancer gene network independently of its demethylase function

Back

Clinical Efficacy of Combined Therapy with LSD1 Antagonist SP-2509 and Pan-Histone Deacetylase Inhibitor Against AML Blast Progenitor Cells.

Back

Inhibition of LSD1 disrupts global EWS/ETS transcriptional function in Ewing sarcoma.

Back

Reversible lysine-specific demethylase 1 antagonist HCI-2509 inhibits growth and decreases c-MYC in castration-and docetaxel-resistant prostate cancer cells.